A new CRISPR-based one-off procedure that lowers "bad" cholesterol has been approved to enter Phase I human trial. If successful, it could be the first approved genetic-silencing method on the market, ...

Extinction has always been final — until now. Advances in genome sequencing, cloning, and genetic engineering have given ...

For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...

How do cutting-edge science and technology respond to ethical and legal issues when incorporated into society? These issues ...

The AHA recommended whole exome or whole genome sequencing as first-line diagnostic tools for mitochondrial diseases.

The platform that slashed NASA's R&D costs and compressed three-day computations into one hour is now available to any ...

The strategy, known as synthetic biology, is gaining momentum globally as a conservation tool and human health solution, ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...

Chinese scientist He Jiankui wants to end Alzheimer’s and thinks Silicon Valley is conducting a “Nazi eugenic experiment.” ...

Discover the innovative TECHNO platform for full-length gene humanisation, enhancing models for human gene function.

Understanding human gene function in living organisms has long been hampered by fundamental differences between species.

FDA alerts and updates on the latest drug and device approvals, recalls, and other regulatory developments in ophthalmology.